Abstract
Background
The medical application of pomegranate fruits and its peel is attracted human beings. The aim of the present study was to evaluate the in vitro α-Glucosidase inhibition, antimicrobial, antioxidant property and in vivo anti-hyperglycemic activity of Punica granatum (pomegranate) fruit peel extract using Caenorhabditis elegans.
Methods
Various invitro antioxidant activity of fruit peel extracts was determined by standard protocol. Antibacterial and antifungal activities were determined using disc diffusion and microdilution method respectively. Anti-hyperglycemic activity of fruit peel was observed using fluorescence microscope for in vivo study.
Results
The ethyl acetate extract of P. granatum fruit peel (PGPEa) showed α-Glucosidase inhibition upto 50 % at the concentration of IC50 285.21 ± 1.9 μg/ml compared to hexane and methanol extracts. The total phenolic content was highest (218.152 ± 1.73 mg of catechol equivalents/g) in ethyl acetate extract. PGPEa showed more scavenging activity on 2,2-diphenyl-picrylhydrazyl (DPPH) with IC50 value 302.43 ± 1.9 μg/ml and total antioxidant activity with IC50 294.35 ± 1.68 μg/ml. PGPEa also showed a significant effecton lipid peroxidation IC50 208.62 ± 1.68 μg/ml, as well as high reducing power. Among the solvents extracts tested, ethyl acetate extract of fruit peel showed broad spectrum of antimicrobial activity. Ethyl acetate extract supplemented C.elegans worms showed inhibition of lipid accumulation similar to acarbose indicating good hypoglycemic activity. The normal worms compared to test (ethyl acetate extract supplemented) showed the highest hypoglycaemic activity by increasing the lifespan of the worms. GC-MS analysis of PGPEa showed maximum amount of 5-hydroxymethylfurfural and 4-fluorobenzyl alcohol (48.59 %).
Conclusion
In the present investigation we observed various biological properties of pomegranate fruit peel. The results clearly indicated that pomegranate peel extract could be used in preventing the incidence of long term complication of diabetics.
Keywords: P. granatum, α-Glucosidase inhibition, Antioxidants activity, Antimicrobial activity, Caenorhabditis elegans, GC-MS analysis
Background
Diabetes mellitus is generally characterized by hyperglycemia that leads to disturbances in the metabolism of carbohydrates, lipids and proteins [1]. Chronic inflammation leads to obesity and it may be prevented by avoiding sugar containing food items. Nowadays insulin therapy is encouraged for the prevention of diabetes mellitus, but the therapy has several side effects like insulin resistance [2], anorexia nervosa, brain atrophy etc. Recently, the use of medicinal plants in modern medicine has been increased in order to prevent or to cure diseases [3–6]. At present food safety is an important concern due to the presence of food borne and other clinical pathogens. The quest for new antimicrobials have been taken into account by researchers worldwide due to the emergence of antibiotic resistant organisms and toxicity of synthetic drugs. Herbal plants and their extracts have been investigated in last few years due to the toxicological concerns of synthetic drugs [7, 8]. The secondary metabolites obtained from medicinal plants have also been investigated for their radical scavenging property.
P. granatum Linn. (Pomegranate) is abundantly present in India and belongs to family Punicaceae. Pomegranate peel contains tannins, flavonoids, polyphenols and some anthocyanins such as cyanidins and delphinidins [9]. Extracts from the peels of pomegranate has been proposed to play vital role in various pharmacological activities [10, 11]. The natural antioxidant food supplement will give the anti- aging process of skin, cells, tissues and organs. Antioxidants are present in certain fruits and vegetables that can protect human cells from oxidative damage and prevent aging of cells and body [12]. It reduces the incidence of tumors and infections. The plant constitutes gallotannic acid and the alkaloid such as isopelletierine, pelletierine, methypelletierine, psuedopelletierine, gallic acid, tannic acie, sugar, cacium oxalate, etc. However, the phytochemical constituents of the plant and antimicrobial activity of this plant have been reported in literature [13, 14]. It is very important to explore the findings of the research by investigation it in vivo and understanding its interactive effect.
C. elegans is a model organism that can be grown cheaply and in large numbers on plates. The worm is preferred over other model organisms especially mouse because they have a short life cycle of only 2 weeks which reduces the experimental cycles and the behaviour of individual cells can be studied because of its transparent body. Additionally, C. elegans genome have functional counterparts in humans which makes it a convenient model for human diseases especially diabetes study.
The nematode Caenorhabditis elegans contains abundant fat droplets in intestinal and hypodermal tissue. Compared to droplets in mammalian adipose tissue, which can expand to sizes of 100 μm [15], C. elegans lipid droplets are small, typically in the size range of 1–1.5 μm [16]. C. elegans has a multistep developmental process due to multicellularilty property. Regulation of lipid droplets inside the nematode using potential herbal extracts will yield key insights into the understanding of obesity, diabetes, and other metabolic diseases [17, 18]. From thios point of view, the present study was evaluated to determine antioxidant activity, α-Glucosidase activity, antimicrobial and antidiabetic property of pomegranate fruit peel extracts.
Methods
Collection of plant
The Healthy fresh pomegranate peel was collected Irula Tribe Women’s Welfare Society (ITWWS), Chengalpet, Tamil Nadu, India. The taxonomical identification of the plants was confirmed by Dr. Jeyajothi, botanist from Loyola College, Chennai, India. The plant was deposited under the vocher number LCH-74 in Loyola College, Chennai.
Plant material and extraction
Peels of P. granatum (pomegranate) were shade dried and subsequently powdered. Five hundred grams of powdered peel was soaked in three different solvents (Hexane, ethyl acetate and methanol) at room temperature for 72 h in rotatory shaker (120 rpm). The powder and solvent were taken in the ratio of 1:3. The filtrates were further concentrated under reduced pressure at 40 °C and stored in a refrigerator at 2–8 °C for use in subsequent experiments.
α-Glucosidase inhibition of solvent extracts
To analyse the α-Glucosidase inhibition, standard methodology was followed with some modifications [19, 20].
Total phenolic content (TPC)
To analyse the total level of phenolic components, Folin–Ciocalteau method was followed with some modifications [20].
DPPH radical scavenging assay of P. granatum fruit peel
DPPH quenching ability of P. granatum fruit peel hexane ether, ethyl acetate and methanol extracts was measured according to Hanato et al. [21].
Evaluation total antioxidant activity of P. granatum fruit peel
The total antioxidant activity of P. granatum fruit peel was determined according to the method of [22].
Lipid peroxidation assay
The evaluated the lipid peroxide properties of the extracts thiobarbituric acid method was followed [20].
Reducing power activity of P. granatum fruit peel
The invitro reducing power activies of the different concnetrations of the plant extract were evaluated by following the standard methodology [3].
Assessment of antimicrobial activity of P. granatum fruit peel
Test organisms
The following bacterial cultures were used to perform antibacterial test using MTCC and ATCC cultures: Escherichia coli MTCC 441, Klebsiella pneumonia ATCC 1705, Streptomyces diastaticus MTCC 1394 and Enterococcus faecalis MTCC 439.
Clinical isolates: Enterobacter aerogenes, Klebsiella pneumoniae, Enterococcus faecalis, Staphylococcus epidermidis, Mycobacterium smegmatis and Escherichia coli and other fungal strains.
Disc diffusion method
The inhibition activity of the extracts against various pathogenic bacteria were determined by folling the standard methodology [3]. Plates were incubated overnight at 37 °C and then the zone of inhibition was measured in mm. All experiments were repeated in triplicate.
Antifungal assays using broth micro dilution method
Antifungal activity was performed according to the standard reference method [23]. The antifungal agent, fluconazole was used as positive control and DMSO was used as negative control.
C. elegans strains and culture conditions
The Bristol N2 (wild-type) C. elegans strain was used in this study and was obtained from Department of Genetic engineering, Madurai Kamaraj University, Tamil Nadu. It was maintained at 20 °C on nematode growth medium (NGM) agar plates. Plates were supplemented with Escherichia coli OP50 as nematode feed.
Fluorescence microscope analysis for lipid accumulation in C.elegans
All worms used in this study were age-synchronized and the experimental animals were grown in liquid M9 medium and raised from eggs obtained by sodium hypochlorite treatment. The extracts of pomegranate fruit peel were made in three different concentrations (100 μg, 300 μg, and 500 μg/mL). They were added to dead OP50 (which were killed by autoclaving) in separate vials. They were then inoculated onto the NGM plates. Twenty worms were inoculated in each plate. Wild-type C. elegans were kept for 5 days under various glucose concentrations in the agar prepared as described above, harvested, and washed. Then drop of Nile Red (0.05 μg/mL) solution were added to the worms, which were then incubated for 30 min, washed with 25 % ethanol twice, and photographed in a Fluorescence microscope (Carl Zeiss Axioplan 2).
Determination of triglycerides
Measurement of tryclycerides is used in screening of the lipid status of the worms. In vitro study was performed using ROBIniK Pritest Triglycerides assay kit using the treated C. elegans worms.
Determination of life span
Synchronized worms were used for life span assay [24]. Twenty number of L4 worms were inoculated in5-fluorodeoxyuridine (FUDR40 mM) plate. The worms were grown at desired temperature (25 °C). The worms were scored every day to find out the activity of the plant extracts on them. The unmoved animals were considered as dead.
GC –MS analysis
The individual compounds present in the extract was determined by GC-MS. The standard operating conditions were followed by the reported literature for GC-MS [3].
Statistical analysis
All the results were analysed in Microsoft Excel 2007.
Results and discussion
Medicinal plants and their extracts have exploited continuously by researchers in order to produce potential drugs of medicinal properties with reduced toxicity. In the line of this, we reported significant in vitro α-glucosidase inhibition activity of ethyl acetate extract of pomegranate peel. The α-glucosidase inhibiting potential of solvent extract such as hexane, ethyl acetate and methanol extracts from the fruit peel were tested and the results are summarized in Table 1. Ethyl acetate extract inhibited alpha glucosidase with the maximum value of 75.6 ± 2.03 % at 500 μg/ml with IC50 value of 285 ± 1.98 μg/ml. Alpha glucosidase inhibiting activity of fruit peel extracts are in the order of ethyl acetate > hexane > methanol.
Table 1.
Sample concentration (μg/ml) | Punica granatum fruit peel | |
---|---|---|
α-Glucosidase inhibition | IC50 (μg/ml) | |
Hexane | ||
100 | 33.6 ± 1.9 | 349 ± 2.20 |
300 | 43.5 ± 2.0 | |
500 | 69.1 ± 2.3 | |
Ethyl Acetate | ||
100 | 38.7 ± 1.98 | 285 ± 1.98 |
300 | 51.5 ± 1.91 | |
500 | 75.6 ± 2.03 | |
Methanol | ||
100 | 20.7 ± 2.2 | 400 ± 2.58 |
300 | 38.1 ± 1.8 | |
500 | 62.0 ± 2.01 | |
Std (Acarbose) | ||
100 | 41.8 ± 1.60 | 205 ± 2.21 |
300 | 56.54 ± 1.91 | |
500 | 80.75 ± 2.08 |
Each value represents the mean ± SEM of triplicate experiments
Pomegranate fruit peel extract potently scavenged DPPH radicals similar to catechin, it is likely that peel extract possessed proton-donating ability and in association with a number of hydroxyl groups to stabilize free radicals [25, 26]. The results of this study suggest that the extracts contain phytochemical constituents that are capable of donating hydrogen to a free radical. Ethyl acetate extract of pomegranate peel has the ability to reduce the stable radical DPPH to diphenylpicryl hydrazine. The different concentrations of solvent extract of pomegranate peel showed antioxidant activities in a concentration-dependent manner (26–71.2 %) in the DPPH scavenging assay. Ethyl acetate extract (100–500 μg/ml) showed the highest activity (30.5–71.2 %). Figure 1 shows the scavenging effects of various extracts of pomegranate fruit peel on DPPH˙ in the following order: ethyl acetate > methanol > hexane.
The total antioxidant capacity of various solvent extracts of pomegranate fruit peel at different concentrations (100–500 μg/ml) was found to be in the following order: ethyl acetate > methanol > hexane (Figs. 2, 3 and 4). Ethyl acetate extract (500 μg/ml) showed the highest total antioxidant activity (69.5 %).
The antibacterial activity of P. granatum fruit peel may be because of the presence of metabolic toxins or broad spectrum antimicrobial compounds that act against both Gram + ve and Gram –ve bacteria. The results of antibacterial activity of ethyl acetate extract of P. granatum (Pomegranate) fruit peel (PGPEa) against various human pathogens are listed in the Table 2. The MIC was significantly lower in ethyl acetate extracts that inhibits T. rubrum and T. mentagrophytes (31.25 μg/ml) (Table 3).
Table 2.
Name of the pathogen | Antibactrerial activity of extract (2.5 mg/ml) | Streptomycin (10 μg/disc) | ||
---|---|---|---|---|
Zone of inhibition (mm) | ||||
Hexane | Ethyl Acetate | Methanol | ||
MTCC Isolates | ||||
Escherichia coli MTCC 441 | 8 ± 1 | 16 ± 1 | 13 ± 2 | 24 ± 1 |
Klebsiella pneumoniae ATCC 1705 | 6 ± 1 | 9 ± 1 | 7 ± 1 | 11 ± 2 |
Streptomyces diastaticus MTCC 1394 | 13 ± 1 | 21 ± 1 | 17 ± 2 | 28 ± 1 |
Enterococcus faecalis MTCC 439 | 6 ± 1 | 12 ± 1 | 13 ± 1 | 14 ± 1 |
Clinical Isolates | ||||
Enterobacter aerogenes | 7 ± 1 | 19 ± 2 | 13 ± 1 | 22 ± 1 |
Klebsiella pneumonia | 6 ± 1 | 14 ± 1 | 15 ± 1 | 19 ± 1 |
Enterococcus faecalis | 7 ± 1 | 15 ± 1 | 16 ± 1 | 21 ± 1 |
Staphylococcus epidermidis | - | 10 ± 1 | - | 16 ± 1 |
Mycobacterium smegmatis | 10 ± 1 | 19 ± 2 | 16 ± 1 | 20 ± 1 |
Escherichia coli | - | 10 ± 2 | - | 24 ± 1 |
The values are the average of three different experiments measuring the zone of inhibition (mm)
Table 3.
S. No | Tested fungi | Hexane (μg/ml) | Ethyl acetate (μg/ml) | Methanol (μg/ml) | Fl (μg/ml) |
---|---|---|---|---|---|
1 | Curvularia lunata 46/01 | 250 | 125 | 125 | 125 |
2 | T. rubrum 57/01 | 250 | 31.2 | 125 | 250 |
3 | T. mentagrophytes 66/01 | 250 | 31.2 | 125 | 250 |
4 | Botrytis cinerea | 250 | 250 | 125 | 250 |
5 | Aspergillus flavus | 250 | 31.2 | 125 | 62.5 |
6 | Aspergillus niger MTCC 1344 | 250 | 62.5 | 125 | 250 |
The MIC values are the average of three different experiments measuring the μg/ml
Fl fluconazole, an antifungal agent
Various investigations were carried out to determine antioxidant, anticarcinogenic, and anti-inflammatory properties of pomegranate constituents [27–29]. Hajoori et al. [30] evaluated the antibacterial activity of different solvent extracts of P. granatum peel against human pathogens including four gram positive bacteria and six gram negative bacteria. According to Rathi et al. [31] P. granatum fruit peel can be used as an easily accessible source of natural antioxidant. They clearly demonstrated broad spectrum antimicrobial activity of pomegranate against bacteria. Additionally they mentioned that the presence of phytocompounds in the extracts including phenols, tannins and flavonoids as major active constituents may be responsible for these activities. Thus, the present study provides a strong direction for proper investigation of pomegranate fruit peel to explore molecules having antimicrobial properties against human pathogens. The presence of active inhibitors in pomegranate fruit peels including phenolics and flavonoids were revealed by phytochemical analysis as potent constituents.
The observed lifespan of C. elegansas model organism (control) was about 17 ± 1 days and the normal worms about 25 ± 1 days sillar to the other reported study [32]. When the observed result of the control was compared with that of the tests, we found that the ethyl acetate extract of P. granatum fruit peel showed the increased lifespan of the worms than that of the control i.e., about 24 ± 1 days. The second highest activity was shown for methanol extract of P. granatum (Table 4).
Table 4.
Extract | Concentration (μg/mL) | Lifespan (Days) |
---|---|---|
Hexane | 100 | 18 ± 1 |
300 | 18 ± 2 | |
500 | 19 ± 2 | |
Ethyl Acetate | 100 | 23 ± 1 |
300 | 24 ± 2 | |
500 | 25 ± 2 | |
Methanol | 100 | 20 ± 1 |
300 | 21 ± 1 | |
500 | 22 ± 1 | |
Control | 100 | 17 ± 1 |
300 | 18 ± 2 | |
500 | 18 ± 1 |
Each value represents the mean ± SEM of triplicate experiments
C. elegans provides a reliable tool to understand the changes in lipid accumulation in the body by glucose concentrations that are within the range observed in poorly controlled diabetic patients [33]. In the present study ethyl acetate extract of pomegranate fruit peel has the ability to reduce the lipid accumulation in the worm body. The fluorescence microscopic analysis clearly shows that ethyl acetate peel extract treated worms have accumulated less lipid compared to the normal worms (Figs. 5 and 6). Reduction in glucose level and lipid content in C.elegans indicates that ethyl acetate extract of pomegranate fruit peel has potential antidiabetic compounds which need to be isolated and identified through chromatographic techniques. Undoubtly ethyl acetate extracts of the test plant showed the presence of diverse molecules when subjected to GC-MS. In PGPEa a total of 48 compounds were detected, out ofwhich the maximum area was found for 5-hydroxymethylfurfural and 4-fluorobenzyl alcohol (Table 5) with a value of 48.59 % (Fig. 7).
Table 5.
S. No | Chemical name | Retention time | % of Area |
---|---|---|---|
1 | 2-furan Carboxamide, N-(3-nitrophenyl)- 1-propanone, 1-(2-furanyl)-4-Pyridinol | 8.266 | 0.60 |
2 | 4H-Pyran-4-one, 3,5-dihydroxy-2-methyl, 4H-Pyran-4-one, 3,5-hydroxy-2-methyl. | 9.425 | 0.62 |
3 | Benzne, 1,3-bis(1,1-dimethylethyl, Benzne, 1,4-bis(1,1-dimethylethyl | 9.552 | 0.31 |
4 | 5-hydroxymethylfurfural, 4-fluorobenzyl alcohol | 9.760 | 48.59 |
5 | 5-hydroxymethylfurfural, 4-mercaptophenol | 10.242 | 2.99 |
6 | 5-hydroxymethylfurfural, 4- fluorobenzyl alcohol | 10.525 | 0.30 |
7 | 5-hydroxymethylfurfural, 4-fluorobenzyl alcohol | 10.621 | 0.39 |
8 | Bicycol [7.2.0] undec-4-ene, 4,11,11-trimethyl-8-methylene, [1R-(1R,4z,9S)]- caryphyllene | 12.107 | 0.38 |
9 | Hexadecane, 1-iodo- Hexadecane Nonane | 12.902 | 0.59 |
10 | Z-8- Hexadecane, 9-Eicosene, (E)- n-Pentadecanol | 14.321 | 0.14 |
11 | Copaene, alpha. Cubebene | 14.989 | 0.29 |
12 | Hexadecane, 2-Bromotetradecane | 15.420 | 0.90 |
13 | Heneicosane, 11-pentyl-Docosane, 11-butyl-Tridecane | 15.561 | 0.54 |
14 | Nonadecane, 9-methyl-Nonane, 5-butyl-Heptadecane | 15.911 | 0.27 |
15 | Z-8-Hexadecane, Pentafluropropinonic acid, 4-hexad ecyl ester | 16.535 | 0.94 |
16 | Heneicosane, Eicosane | 17.649 | 0.63 |
17 | Nonadecane, 9-methyl, 7,9-Di-tert-butyl-1-oxaspiro(4,5)deca-6,9-diene-2,8-dione. | 17.731 | 0.68 |
18 | Pentadecanoic acid, 14-methyl easter, Hexadecanoic acid, methyl easter | 17.939 | 0.81 |
19 | Nonadecane, 9-methyl, Eicosane, Pentacosane | 18.080 | 0.34 |
20 | 1-heneicosyl formate, Cyclooctacosane, 9-Tricosen, (Z)- | ||
21 | Tetracosane, Octodecane, Hexadecane | 19.543 | 0.48 |
22 | Triacontane, 1-bromo-1-Chloroeicosane Heptadecane | 19.595 | 0.59 |
23 | Dodecane, 2,6,11-trimethyl-docosane, 7-hexyl-Tetracosane | 19.677 | 1.98 |
24 | Linoleic acid ethyl ester n-Propyl 9, 12-octadecadienoate 9, 12-octadecadienoic acid, ethyl ester | 20.137 | 0.53 |
25 | 1-nonadecene, 9-Trocosene, (Z)- Bacchotricuneatin | 20.204 | 0.63 |
26 | 1-nonadecene, 9-Trocosene, Z-5- Nonadecene | 20.412 | 0.71 |
27 | Tetracosane, Octadecane, Heptadecane | 20.457 | 0.50 |
28 | 6-octen-1-ol, 3,7-dimethyl acetate Phytol, acetate 1,2-15, 16-Diepoxyhexadecane | 20.583 | 2.02 |
29 | 3,5,7-Tricyclopropyl-5,6-dihydro-5-methyl-1,2(4H)-diazepineOctanoic acid, but-3-yn-2-yl ester Ethisterone | 20.888 | 1.14 |
30 | Triacontane, Heptadecane, Octacosane | 21.333 | 0.39 |
31 | 3H-Cyclodeca[b]furan-2-one, 4, 9-dihydroxy-6-methyl-3, 10-dimethylene-3a, 4, 7, 8, 9, 10, 11, 11a-octahydro-Bicyclo[10.1.0]trideca-4, 8-diene-1 3-carboxamide, N-(3-chlorophenyl)-1H-2, 8a-Methanocyclopenta[a]cyclopropa[e]cyclodecen-11-one, 1a, 2, 5, 5a, 6, 9, 10, 10a-octahydro-5, 5a, 6-trihydroxyl-1, 4-bis(hydroxymethyl)-1, 7, 9-trimethyl, [1S-(1.alpha., 1a.alpha., 2.alpha., 5.beta., 5a.beta., 6.beta., 8a.aipha., 9.alpha., 10a.alpha.)] | 21.437 | 0.83 |
32 | Heptadecane, 3-methyl- OctadecaneNonadecane | 21.512 | 1.41 |
33 | Octacosane, Tetracosane | 22.165 | 0.81 |
34 | Eicosane, Triacotane, Octadecane | 22.975 | 0.42 |
35 | Hexatriacontane, Octadecane, 1-iodo-Tetratetracontane | 23.205 | 0.37 |
36 | 1-hexacosene, 9-hexacosene, E-15-heptadecenal | 23.725 | 0.37 |
37 | Squalene | 25.300 | 1.07 |
38 | Eicosane, Heneicosane, | 25.924 | 0.56 |
39 | Vitamin E (+)-gamma- Tocopherol, O-methyl-dl-alpha.- Tocopherol | 27.499 | 0.96 |
40 | CyclobarbitalTris(tert-butyldimethylsilyloxy)arsane, 1H-Indole-2-carboxylic acid, 6-(4- ethoxyphenyl)-3-methyl-4-oxo-4, 5, 6, 7-tetrahydro isopropyl ester | 27.573 | 0.41 |
41 | 2, 4-Cyclohexadien- 1-one, 3, 5-bis, 1-dimethylethyl)- 4-hydroxy- Tetrasiloxane, decamethyl- Benz[b]-1, 4-oxazepine-4(5H)-thione, 2, 3-dihydro-2, 8-dimethyl | 28.695 | 0.69 |
42 | Anthracene, 9, 10- dihydro-9, 9, 10-trimethyl-1H- Indole, 1-methyl-2-phenyl-Ethanone, 2-(2-benzothiazolylthio)-1-(3, 5-dimethylpyralyl) | 29.082 | 1.52 |
43 | N-Methyl-1-adamantaneacetamide Arsenous acid, tris(trimethylsilyl) ester, Benzo[h]quinolone, 2, 4-dimethyl | 29.275 | 0.69 |
44 | 9, 19-cyclolanost-24-en-3-ol, Lanosterol, Lanost-7-en-3-one | 29.512 | 7.37 |
45 | Tirucallol, Lanosterol, D:B-Friedo-18, 19-secolup-19-ene, 10-epoxy | 29.943 | 7.58 |
46 | 1, 2-Bis(trimethylsilyl) benzene, 4-Dehydroxy-N-(4, 5-methylenedioxy- 2-nitrobenzylidene) tyramineBenzo[h]quinolone, 2, 4-dimethyl | 30.382 | 1.48 |
47 | 1H-Indole, 1-methyl-2-phenyl- Arsenous acid, tris(trimethylsilyl) ester, Cyclotrisiloxane, hexamethyl | 30.864 | 0.86 |
48 | 5-methyl-2-phenylindozine (1H) Pyrrole-3-carboxylic acid, 5-[cyano(4-morpholinyl) methyl]-1-(methoxymethyl), methyl ester 2- (Acetoxymethyl)-3-(methoxycarbonyl) biphenylene | 31.533 | 1.06 |
Conclusion
It is concluded that the ethyl acetate extract of pomegranate fruit peel contained considerable levels of phenols and flavonoids which are responsible for α-glucosidase inhibition and antioxidant activities. These in vitro assays also indicate that the PGPEa not only has potential antidiabetic and natural antioxidant compounds but also has the ability to increases the life span of C. elegans. Future studies are required to prove whether the process described in C. elegans can be translated to the situation in diabetic patients. 5-hydroxymethylfurfural and 4-fluorobenzyl alcohol compounds detetcted in GCMS might plaied the role in antioxidant and antimicrobial potentials of the extracts.
Abbreviations
GC-MS, gas chromatography–mass spectrometry
Acknowledgement
We would like to thank Department of Biotechnology, India (Indo-Spain Collaborative project, Ref. No. - BT/IN/Spain/19/PA/2013) for financial assistance. This study was supported by grants from the Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ0102212014), Rural Development Administration, Korea. The authors extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding this Prolific Research Group (PRG-1437-28).
Availability of data and materials
All data and materials were given in the manuscript. We have further data and materials.
Authors’ contributions
KBK, BV and AK carried out the experimental part of the manuscript. KBK, NAA-D, BV, AK and MVA analyzed the antimicrobial, antioxidant and in vivo studies. KBK, MVA, HSC, and PA participated in its design and coordination and helped to draft the manuscript. HSC, YOC and PA involved in analyzing and monitoring the data and experiment. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Financial disclosure
India (Indo-Spain Collaborative project, Ref. No. - BT/IN/Spain/19/PA/2013); South Korea (Project No. PJ0102212014), Saudi Arabia (PRG-1437-28).
Contributor Information
Mariadhas Valan Arasu, Email: mvalanarasu@gmail.com.
Han Sung Choi, Email: hsg3748@hanmail.net.
Young Ock Kim, Email: kyo9128@korea.kr, Email: kyo9128@gmail.com.
References
- 1.Sharma AK. In: Diabetes mellitus and its complications: An update. 1. Sharma AK, editor. New Delhi: Macmillan India Ltd; 1993. pp. 92–205. [Google Scholar]
- 2.Piedrola G, Novo E, Escober F, Garcia-Robles R. White blood cell count and insulin resistance in patients with coronary artery disease. Ann Endocrinol. 2001;62(1):7–10. [PubMed] [Google Scholar]
- 3.Glorybai L, Kannan KB, Arasu MV, Al-Dhabi NA, Agastian P. Some biological activities of Epaltes divaricata L. – anin vitro study. Ann Clin Microbiol Antimicrob. 2015;14(18):1–11. doi: 10.1186/s12941-015-0074-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Balamurugan R. Smilax chinensis Linn. (Liliaceae) root attenuates insulin resistance and ameliorate obesity in high diet induced obese rat. South Ind J Biol Sci. 2015;1:47–51. [Google Scholar]
- 5.Vigouroux C, Caron-Debarle M, Le Dour C, Magre J, Capeau J. Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity. Int J Biochem Cell Biol. 2011;43(6):862–876. doi: 10.1016/j.biocel.2011.03.002. [DOI] [PubMed] [Google Scholar]
- 6.Sztalryd C, Kimmel AR. Perilipins: lipid droplet coat proteins adapted for tissue-specific energy storage and utilization, and lipid cytoprotection. Biochimie. 2014;1:96–101. doi: 10.1016/j.biochi.2013.08.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Mahboubi A, Asgarpanah J, Sadaghiyani PN, Faizi M. Total phenolic and flavonoid content and antibacterial activity of Punica granatum L. var. pleniflora flowers (Golnar) against bacterial strains causing foodborne diseases. BMC Complement Altern Med. 2015;15(1):1. doi: 10.1186/s12906-015-0887-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Dastjerdi EV, Abdolazimi Z, Ghazanfarian M, Amdjadi P, Kamalinejad M, Mahboubi A. Effect of Punica granatum L. flower water extract on five common oral bacteria and bacterial biofilm formation on orthodontic wire. Iran J Public Health. 2014;12:1688. [PMC free article] [PubMed] [Google Scholar]
- 9.Li Y, Guo C, Yang J, Wei J, Xu J, Cheng S. Evaluation of antioxidant properties of pomegranate peel extract in comparison with pomegranate pulp extract. Food Chem. 2006;96(2):254–260. doi: 10.1016/j.foodchem.2005.02.033. [DOI] [Google Scholar]
- 10.Antonisamy P, Duraipandiyan V, Ignacimuthu S, Kim JH. Anti-diarrhoeal activity of friedelin isolated from Azima tetracantha Lam. in Wistar rats. South Ind J Biol Sci. 2015;1:34–37. [Google Scholar]
- 11.Middleton E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: Implication for inflammation, heart disease and cancer. Pharmacol Rev. 2000;52(4):673–681. [PubMed] [Google Scholar]
- 12.Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev. 2010;4(8):118–126. doi: 10.4103/0973-7847.70902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Simoes M, Bennett RN, Rosa EA. Understanding antimicrobial activities of phytochemicals against multidrug resistant bacteria and biofilms. Nat Prod Rep. 2009;26(6):746–757. doi: 10.1039/b821648g. [DOI] [PubMed] [Google Scholar]
- 14.Rangasamy K, Namasivayam E. In vitro Antioxidant and Free Radical Scavenging Activity of Isolongifolene. Asian J Biol Sci. 2014;7(1):13–23. doi: 10.3923/ajbs.2014.13.23. [DOI] [Google Scholar]
- 15.Suzuki M, Shinohara Y, Ohsaki Y, Fujimoto T. Lipid droplets: size matters. J Electron Microsc. 2011;60(1):S101–S116. doi: 10.1093/jmicro/dfr016. [DOI] [PubMed] [Google Scholar]
- 16.Shi X, Li J, Zou X, Greggain J, Rodkaer SV, Faergeman NJ, Liang B, Watts JL. Regulation of lipid droplet size and phospholipid composition by stearoyl-CoA desaturase. J Lipid Res. 2013;54(9):2504–2514. doi: 10.1194/jlr.M039669. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Martin S, Parton RG. Lipid droplets: A unified view of a dynamic organelle. Nat Rev Mol Cell Biol. 2006;7(5):373–378. doi: 10.1038/nrm1912. [DOI] [PubMed] [Google Scholar]
- 18.Farese RV, Walther TC. Lipid droplets finally get a little R-E-S-P-E-C.-T. Cell. 2009;139(5):855–860. doi: 10.1016/j.cell.2009.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Dahlqvist A. Method for assay of intestinal disaccharidases. Anal Biochem. 1964;7(1):18–25. doi: 10.1016/0003-2697(64)90115-0. [DOI] [PubMed] [Google Scholar]
- 20.Nimal Christhudas IVS, Praveen Kumar P, Sunil C, Vajravijayan S, Lakshmi Sundaram R, Jenifer Siril S, Agastian P. In vitro studies on a-glucosidase inhibition, antioxidant and free radical scavenging activities of Hedyotis biflora L. Food Chem. 2013;138:1689–1695. doi: 10.1016/j.foodchem.2012.11.051. [DOI] [PubMed] [Google Scholar]
- 21.Hatano T, Kagawa H, Yasuhara T, Okuda T. Two new flavonoids and other constituents in licorice root: Their relative astringency and radical scavenging effects. Chem Pharm Bull. 1988;36(6):1090–2097. doi: 10.1248/cpb.36.2090. [DOI] [PubMed] [Google Scholar]
- 22.Roa KS, Nargesh KK, Ravi KBVV. A comparative study of polyphenoliccomposition and in vitro antioxidant activity of Illicium verum extracted by microwave and soxhlet extraction techniques. Ind J Pharm Educ. 2012;46(3):228–234. [Google Scholar]
- 23.Clinical and Laboratory Standards Institute (CLSI) Approved Standard. 3. Wayne: CLSI; 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; pp. M27–A3. [Google Scholar]
- 24.Sutphin GL, Kaeberlein M. Measuring Caenorhabditis elegans life span on solid media. J Vis Exp. 2011;49:2496. doi: 10.3791/1152. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Nair RK, Haridas A, Ezhuthupurakkal DR. Diversity and comparative account on phytochemical and antioxidant properties of two varieties of Musa, Nendran and Kunnan. South Ind. J Biol Sci. 2016;2(1):203–206. [Google Scholar]
- 26.Brand-Williams W, Cuvelier M, Berset C. Use of a free radical method to evaluate antioxidant activity. Lebensm-Wiss Technol. 1995;28(1):25–30. doi: 10.1016/S0023-6438(95)80008-5. [DOI] [Google Scholar]
- 27.Noorudheen N, Chandrasekharan DK. Effect of ethanolic extract of Phyllanthus emblica on captan induced oxidative stress in vivo. South Ind J Biol Sci. 2016;2:95–103. [Google Scholar]
- 28.Adhami VM, Khan N, Mukhtar H. Cancer Chemoprevention by Pomegranate: Laboratory and Clinical Evidence. Nutr Cancer. 2009;61(6):811–815. doi: 10.1080/01635580903285064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Al-Zoreky NS. Antimicrobial activity of pomegranate (Punica granatum L.) fruit peels. Int J Food Microbiol. 2009;134(3):244–248. doi: 10.1016/j.ijfoodmicro.2009.07.002. [DOI] [PubMed] [Google Scholar]
- 30.Hajoori M, Naik M, Naik K, Desai S. Evaluation of antimicrobial activity of Punica granatum peel extracts using different solvent system. Int J Pharmacol Screen Methods. 2014;4(1):26–31. [Google Scholar]
- 31.Rathia P, Rajput CS, Singhal S. Evaluation of total phenolic contents, antioxidant and antibacterial capacity of aqueous methanolic extracts obtained from Punica granatum peel. Int J Pharm Sci Rev Res. 2014;25(2):92–94. [Google Scholar]
- 32.Rathi MA, Meenakshi P, Gopalakrishnan VK. Hepatoprotective activity of ethanolic extract of Alysicarpus vaginalis against nitrobenzene-induced hepatic damage in rats. South Ind J Biol Sci. 2015;1(2):60–65. [Google Scholar]
- 33.Schlotterer A, Kukudov G, Bozorgmehr F, Hutter H, Du X, Oikonomou D, et al. C. elegans as Model for the Study of High Glucose–Mediated Life Span Reduction. Diabetes. 2009;58(11):2450–2456. doi: 10.2337/db09-0567. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
All data and materials were given in the manuscript. We have further data and materials.